| Ticker: | JNGLX |
| Manager: | Andrew Acker |
| Manager Since: | 05/07 |
| NAV (04/14/2011): | 25.38 |
| Objective: | Equity - Sector Health |
| Peer: | HL LG |
| Net Assets ($mil): | 559.00 |
| Inception: | 12/31/1998 |
JNGLX : Description
NA
JNGLX : Composition - 05/13
| Stocks | 98.38% |
| Foreign Stocks | 22.77% |
| Cash | 0.63% |
| Bonds | 0.99% |
| Foreign Bonds | 0.00% |
| Preferred | 0.00% |
| Convertible | 0.00% |
| Other | 0.00% |
| Foreign Hedged | 0.00% |
JNGLX : Style Analysis - 05/13
| Large Growth | 60.99% |
| Large Value | 0.00% |
| Small Growth | 0.00% |
| Small Value | 0.00% |
| Foreign Stock | 60.99% |
| Emerging Market | 11.58% |
| Precious Metals | 0.00% |
| Intermediate Bond | 0.00% |
| High Yield Bond | 0.00% |
| Foreign Bond | 0.00% |
JNGLX : Risk Analysis
| Beta v. S&P 500 | 0.78 |
| Beta v. EAFE | 0.06 |
| Beta v. Barclays Agg Bond | 0.35 |
| Alpha 3 Yr | 8.03 |
| Alpha 5 Yr | 6.57 |
| R-Sq 3 Yr | 0.80 |
| R-Sq 5 Yr | 0.72 |
| Std Dev 3 Yr | 13.87 |
| Std Dev 5 Yr | 17.15 |
| Sharpe 3 Yr | 1.46 |
| Sharpe 5 Yr | 0.71 |
JNGLX : Fees
| Expense Ratio | 0.90 |
| % Max Load | NA |
| % Min Load | NA |
| % Deferred Load | NA |
| % Redemption | NA |
| % Max 12 B1 Fee | 0.00 |
| % Max Mgt Fee | 0.64 |
JNGLX : Purchase Choices:
| Min Initial Investment | CLOSED |
| Min Subsequent Investment | 100 |
JNGLX : Returns Analysis - Annual
| 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | YTD | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAV ($) | 15.65 | 17.99 | 20.05 | 19.66 | 24.09 | 17.13 | 21.59 | 23.24 | 24.90 | 29.95 | 25.38 |
| Total Return (%) | 27.44 | 14.95 | 11.45 | -1.94 | 22.53 | -28.77 | 26.30 | 8.19 | 7.30 | 24.74 | 19.49 |
| Annual Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.16 | 0.48 | 0.13 | 0.00 | 0.00 |
| Relative Performance | |||||||||||
| Rel Performance-S&P500(%) | -12.49 | 40.79 | 65.60 | -177.41 | 170.38 | 82.33 | -1.19 | -68.72 | 52.05 | 87.51 | 67.56 |
| Rel Performance-Obj.Ret.(%) | -31.03 | 61.72 | 24.88 | -56.80 | 136.68 | -50.78 | 44.25 | 1.67 | -4.44 | 55.12 | -0.83 |
| Ret.Quintile vs Obj(1 is best) | 4 | 1 | 3 | 5 | 1 | 5 | 2 | 3 | 3 | 1 | 3 |
| Turnover, Yields, and Gains | |||||||||||
| Fund Assets Net($mil) | 1,273 | 1,184 | 1,119 | 982 | 894 | 592 | 646 | 433 | 421 | 559 | 559 |
| Annual Turnover (%) | 78.00 | 90.00 | 87.00 | 61.00 | 81.00 | 70.00 | 46.00 | 54.00 | 50.00 | 0.00 | |
| Annual Dividend Paid ($) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.03 | 0.11 | 0.03 | 0.00 | 0.00 |
| Annual Capital Gains Paid($) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.12 | 0.00 |
JNGLX : Returns Analysis - Trailing Total Return
| 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year | 10 Year | 15 Year | 20 Year | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Return (through 05/13) | 4.16% | 11.04% | 23.35% | 19.49% | 28.35% | 19.26% | 10.73% | 11.29% | NA | NA |
| Ret. Percentile vs. Obj. (1 is best) | 25 | 52 | 25 | 46 | 38 | 24 | 52 | 29 | NA | NA |
JNGLX : Stock Portfolio Snapshot - 05/13
| Average Price/Earnings | 28.01 |
| Average Price/Book | 5.70 |
| Average EPS Growth | 13.32 |
| Average Market Value | 20,928.00 |
JNGLX : Stock Sector Breakout - 05/13
JNGLX : Top Holdings - 05/13
| Name | Weight | Shares |
|---|---|---|
| AETNA INC | 3.96 | 713,505 |
| GILEAD SCIENCES INC | 3.91 | 444,007 |
| CELGENE CORP | 3.66 | 387,159 |
| EXPRESS SCRIPTS INC | 3.55 | 547,659 |
| AMERISOURCEBERGEN CORP | 1.98 | 382,582 |
| MEDIVATION INC | 2.68 | 436,956 |
| SHIRE PLC | 2.34 | 211,635 |
| OMNICARE INC | 2.31 | 533,350 |
| VALEANT PHARMACEUTICALS | 2.99 | 417,569 |